Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe author list for the DREAMM-2 publication has been removed. The page now includes a Show glossary option and new update metadata such as Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page now includes a 'Multiple myeloma' topic and a MedlinePlus Genetics related topics link, which are navigational/contextual additions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now shows a revision tag updated to v3.3.4, with references to the previous revision v3.3.3 and to topics such as Multiple myeloma and MedlinePlus Genetics removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedThe study page now includes a 'Multiple myeloma' disease tag and a related topic link to 'MedlinePlus Genetics', enhancing navigation and indexing.SummaryDifference0.1%

- Check40 days agoChange DetectedA new Locations section lists trial sites across multiple U.S. states and international locations, and the page metadata shows Revision: v3.3.3.SummaryDifference2%

- Check48 days agoChange DetectedAdded 'Multiple myeloma' as a disease keyword and linked a related topic to MedlinePlus Genetics.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.